Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) Sees Large Growth in Short Interest

Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) saw a large growth in short interest in October. As of October 31st, there was short interest totalling 123,200 shares, a growth of 27.1% from the October 15th total of 96,900 shares. Based on an average trading volume of 120,900 shares, the short-interest ratio is presently 1.0 days. Currently, 0.7% of the company’s stock are sold short.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Inspira Technologies Oxy B.H.N. stock. Renaissance Technologies LLC bought a new stake in Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 24,497 shares of the company’s stock, valued at approximately $34,000. Renaissance Technologies LLC owned approximately 0.19% of Inspira Technologies Oxy B.H.N. at the end of the most recent quarter. 12.72% of the stock is owned by institutional investors.

Inspira Technologies Oxy B.H.N. Trading Down 2.4 %

NASDAQ:IINN opened at $1.22 on Friday. Inspira Technologies Oxy B.H.N. has a 52-week low of $0.76 and a 52-week high of $2.49. The company has a quick ratio of 2.13, a current ratio of 2.23 and a debt-to-equity ratio of 0.09. The stock’s 50-day simple moving average is $1.31 and its 200 day simple moving average is $1.45.

Inspira Technologies Oxy B.H.N. Company Profile

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.